Goldman Sachs Downgrades SAFEWAY (SWY) to Sell
Tweet
Share
E-mailGet Alerts SWY Hot Sheet
Price: $35.10 --0%
Rating Summary:
4 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
4 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
Goldman Sachs downgraded SAFEWAY (NYSE: SWY) to Sell with a price target of $20 (from $25).
The firm advocates "leaning into secular stories with accelerating fundamentals (WFM, CL-Buy) and out of mature, share donors (SWY) (KR) as cyclical tailwinds moderate." They also said valuation remains full relative to peers.
Goldman said the company's Q2 results showed that even modest inflation pressured margins on meager identical store sales growth.
The firm lowered FY11E-FY13E EPS for SWY by 7%-9% to reflect a weaker sales and margin outlook
For more ratings news on SAFEWAY click here and for the rating history of SAFEWAY click here.
Shares of SAFEWAY closed at $20.93 yesterday.
The firm advocates "leaning into secular stories with accelerating fundamentals (WFM, CL-Buy) and out of mature, share donors (SWY) (KR) as cyclical tailwinds moderate." They also said valuation remains full relative to peers.
Goldman said the company's Q2 results showed that even modest inflation pressured margins on meager identical store sales growth.
The firm lowered FY11E-FY13E EPS for SWY by 7%-9% to reflect a weaker sales and margin outlook
For more ratings news on SAFEWAY click here and for the rating history of SAFEWAY click here.
Shares of SAFEWAY closed at $20.93 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GLJ Research Downgrades Fluence Energy Inc. (FLNC) to Hold
- RBC Capital Downgrades Temple & Webster Group Ltd (TPW:AU) to Sector Perform
- Jefferies Downgrades Sunway Healthcare Holdings (SUNMED:MK) to Hold
Create E-mail Alert Related Categories
Downgrades, Hot DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
